z-logo
open-access-imgOpen Access
The blood-brain barrier limits the therapeutic efficacy of antibody-drug conjugates in glioblastoma
Author(s) -
Roger Abounader,
David Schiff
Publication year - 2021
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/noab223
Subject(s) - glioblastoma , blood–brain barrier , drug , antibody drug conjugate , antibody , medicine , conjugate , pharmacology , cancer research , monoclonal antibody , immunology , central nervous system , mathematical analysis , mathematics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom